Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem ; 26(23-24): 6146-6152, 2018 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-30446437

RESUMEN

Non-secosteroidal VDR ligands without any assymmetric carbon were designed and synthesized based on the structure of the previously reported non-secosteroidal VDR agonist LG190178. The VDR-agonistic activity of all synthesized compounds was evaluated, and 7b emerged as a potent agonist activity with an EC50 value of 9.26 nM. Moreover, a docking simulation analysis was also performed to determine the binding mode of 7b with VDR-LBD.


Asunto(s)
Compuestos de Bifenilo/farmacología , Receptores de Calcitriol/agonistas , Compuestos de Bifenilo/síntesis química , Compuestos de Bifenilo/química , Relación Dosis-Respuesta a Droga , Humanos , Ligandos , Modelos Moleculares , Estructura Molecular , Relación Estructura-Actividad
2.
J Steroid Biochem Mol Biol ; 148: 34-7, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25263656

RESUMEN

Three different A-ring perhydroxylated trihydroxyvitamin D3 metabolites were synthesized from their appropriate A-ring precursors and CD-ring for their potential therapeutic applications. We first chemically synthesized 1α,2α,25-trihydroxyvitamin D3 [1α,2α,25(OH)3D3] to study its VDR binding affinity because this metabolite is a product of recombinant human CYP3A4 catalysis when 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (O2C3), a more potent vitamin D receptor (VDR) binder than 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3], is used as the substrate. We found that this metabolite retained 27.3% of the VDR binding affinity compared to 1α,25(OH)2D3. The kcat/Km value of CYP24A1 for 1α,2α,25(OH)3D3 is 60% of that for 1α,25(OH)2D3. Since the biological activity and the metabolic fate of a naturally occurring C4-hydroxylated vitamin D2 metabolite found in the serum of rats treated with pharmacological doses of vitamin D2 have never been described, we next synthesized 1α,4α,25-trihydroxyvitamin D3 and its diastereoisomer, 1α,4ß,25-trihydroxyvitamin D3, to study their metabolism and biological activities. Both 4-hydroxylated isomers showed weaker VDR binding affinity than 1α,25(OH)2D3. Although either 4-hydroxylated isomer can be metabolized by CYP24A1 almost at the same level as 1α,25(OH)2D3, their metabolic patterns catalyzed by uridine 5'-diphosphoglucuronosyltransferase (UGT) are different; only the 4α-hydroxylated analog can be metabolized by UGT to produce a glucuronate conjugate. The results provide important information for the synthesis of new novel chemotherapeutic vitamin D analogs which would be less subjective to degradation and therefore more bioavailable than 1α,25(OH)2D3. This article is part of a Special Issue entitled '17th Vitamin D Workshop'.


Asunto(s)
Calcitriol/síntesis química , Calcitriol/farmacología , Vitaminas/síntesis química , Vitaminas/farmacología , Animales , Calcitriol/análogos & derivados , Humanos , Estructura Molecular , Ratas , Estereoisomerismo
3.
J Steroid Biochem Mol Biol ; 144 Pt A: 201-3, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24036313

RESUMEN

X-ray cocrystallographic studies of the human vitamin D receptor (hVDR)-[2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (O1C3)] complex showed that the terminal hydroxy group of the 2α-functional group of O1C3 formed a hydrogen bond with Arg274 in the ligand binding domain (LBD) of hVDR to stabilize the complex; therefore, O1C3 showed 3-times greater binding affinity for VDR than the natural hormone. Here, the effects of a heteroaromatic ring on binding to hVDR instead of the terminal OH group of O1C3 and also on preliminary biological activities were studied. We synthesized 2α-[2-(tetrazol-2-yl)ethyl]-1α,25(OH)2D3 (1a) and its regioisomer 2α-[2-(tetrazol-1-yl)ethyl]-1α,25(OH)2D3 (1b), in which 1a showed much higher hVDR binding affinity and greater osteocalcin promoter transactivation activity in human osteosarcoma (HOS) cells than those of 1b. X-ray cocrystallographic analysis of the hVDR-1a complex showed new hydrogen bond formation between one of the nitrogen atoms of the tetrazole ring and Arg274. This article is part of a Special Issue entitled '16th Vitamin D Workshop'.


Asunto(s)
Antineoplásicos/síntesis química , Calcitriol/análogos & derivados , Diseño de Fármacos , Receptores de Calcitriol/metabolismo , Vitaminas/síntesis química , Antineoplásicos/farmacología , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/metabolismo , Neoplasias Óseas/patología , Calcitriol/síntesis química , Calcitriol/farmacología , Humanos , Osteosarcoma/tratamiento farmacológico , Osteosarcoma/metabolismo , Osteosarcoma/patología , Relación Estructura-Actividad , Vitaminas/farmacología
4.
J Steroid Biochem Mol Biol ; 136: 3-8, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23416104

RESUMEN

Up to the present, numerous vitamin D derivatives have been synthesized, but most of them have straight side chains, and there are few publications described about in vitro and in vivo evaluations on bone by vitamin D derivatives. In our previous paper, we reported the synthesis of various C-2 substituted vitamin D derivatives (2b-2i) with a 2,2-dimethylcyclopentanone unit in the CD-ring side chains, and that the derivatives have strong activity for enhancing bone growth. On the basis of results, this time, we report the synthesis of 2α-substituted vitamin D3 derivatives with chiral cyclopentanone (3-6 and 12-16). These derivatives were obtained by Pd-coupling reaction with A-ring precursor and CD-rings precursor. We evaluated novel derivatives in vitro assays, for affinities for VDR and transactivation assays by human osteosarcoma (HOS) cells. In this research, we demonstrated that some novel vitamin D derivatives (12-MP, 13-MP, 15-MP and 16-LP) have strong transactivation activities in spite of lower affinity for VDR than 1. In addition, we also demonstrated that these derivatives have strong activities for enhancing bone growth using OVX therapeutic rats. This article is part of a Special Issue entitled 'Vitamin D Workshop'.


Asunto(s)
Vitamina D/análogos & derivados , Animales , Densidad Ósea/efectos de los fármacos , Técnicas de Química Sintética , Cristalografía por Rayos X , Femenino , Humanos , Modelos Moleculares , Estructura Molecular , Osteoporosis/tratamiento farmacológico , Osteoporosis/metabolismo , Ratas , Receptores de Calcitriol/química , Receptores de Calcitriol/metabolismo , Relación Estructura-Actividad , Vitamina D/síntesis química , Vitamina D/farmacología
5.
ACS Med Chem Lett ; 4(7): 671-4, 2013 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-24900728

RESUMEN

2α-Heteroarylethyl-1α,25-dihydroxyvitamin D3 analogues, which were designed to form a hydrogen bond between Arg274 of human vitamin D receptor (hVDR) and a nitrogen atom of the heteroaromatic ring at the 2α-position, were synthesized. Among them, 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 showed higher osteocalcin promoter transactivation activity in human osteosarcoma (HOS) cells and a greater therapeutic effect in ovariectomized (OVX) rats, osteoporosis model animals, on enhancing bone mineral density than those of active vitamin D3. X-ray cocrystallographic analysis of the hVDR-ligand complex confirms that the new hydrogen bond formation stabilized the complex.

6.
Bioorg Med Chem Lett ; 21(20): 6104-7, 2011 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-21889334

RESUMEN

We designed and synthesized nonsecosteroidal vitamin D receptor (VDR) ligands that formed H-bonds with six amino acid residues (Tyr143, Ser233, Arg270, Ser274, His301 and His393) of the VDR ligand-binding domain. The ligand YR335 exhibited potent transcriptional activity, which was comparable to those of 1α,25-dihydroxyvitamin D(3) and YR301. The crystal structure of the complex formed between YR335 and the VDR ligand-binding domain was solved, which revealed that YR335 formed H-bonds with the six amino acid residues mentioned above.


Asunto(s)
Diseño de Fármacos , Receptores de Calcitriol/metabolismo , Animales , Cristalografía por Rayos X , Ligandos , Modelos Moleculares , Unión Proteica , Ratas , Receptores de Calcitriol/química
7.
Org Lett ; 13(11): 2852-5, 2011 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-21539305

RESUMEN

C15-Substituted 1α,25-dihydroxyvitamin D(3) analogs were synthesized for the first time to investigate the effects of the modified CD-ring on biological activity concerning the agonistic positioning of helix-3 and helix-12 of the vitamin D receptor (VDR). X-ray cocrystallographic analysis proved that 0.6 Å shifts of the CD-ring and shrinking of the side chain were necessary to maintain the position of the 25-hydroxy group for proper interaction with helix-12. The 15-hydroxy-16-ene derivative showed higher binding affinity for hVDR than the natural hormone.


Asunto(s)
Calcitriol , Receptores de Calcitriol/metabolismo , Calcitriol/análogos & derivados , Calcitriol/síntesis química , Calcitriol/química , Calcitriol/metabolismo , Cristalografía por Rayos X , Humanos , Conformación Molecular , Estructura Molecular
8.
Org Biomol Chem ; 9(10): 3954-64, 2011 May 21.
Artículo en Inglés | MEDLINE | ID: mdl-21472188

RESUMEN

In order to obtain vitamin D derivatives, which have strong activity for enhancing bone growth, we designed vitamin D derivatives with various substitutions at the C-2 position. Novel 2 α-substituted vitamin D derivatives were synthesized starting from d-glucose as a chiral template of the A-ring with a CD-ring bromoolefin unit using the Trost coupling method. We evaluated these compounds by two in vitro assays, affinity to VDR and transactivation assays, using human osteosarcoma (Hos) cells, and demonstrated the SAR of the C-2 position of VD(3). Furthermore, by using the OVX model, we found that compound 5c, which has a hydroxypropoxy side chain at C-2 and 2,2-dimethyl cyclopentanone in the CD-ring side chain, has a strong activity for enhancing bone growth, same as the reported compound, 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D(3)1d, and this derivative shows a possibility that calcemic activity is less than 1d in vivo.


Asunto(s)
Huesos/efectos de los fármacos , Vitamina D/síntesis química , Vitamina D/farmacología , Animales , Densidad Ósea/efectos de los fármacos , Huesos/fisiología , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Diseño de Fármacos , Femenino , Humanos , Ovariectomía , Ratas , Receptores de Calcitriol/metabolismo , Relación Estructura-Actividad , Activación Transcripcional/efectos de los fármacos , Vitamina D/análogos & derivados , Vitamina D/metabolismo
9.
Dev Growth Differ ; 50(9): 703-16, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19046159

RESUMEN

The medaka fish (Oryzias latipes) is an emerging model organism for which a variety of unique developmental mutants have now been generated. Our recent mutagenesis screening of the medaka isolated a unique mutant that develops a fatty liver at larval stages. Positional cloning identified the responsible gene as medaka abcb7. Abcb7, a mitochondrial ABC (ATP binding cassette) half-transporter, has been implicated in iron metabolism. Recently, human Abcb7 was found to be mutated in X-linked sideroblastic anemia with cerebellar ataxia (XLSA/A). The homozygous medaka mutant exhibits abnormal iron metabolism in erythrocytes and accumulation of lipid in the liver. Microarray and in situ hybridization analyses demonstrated that the expression of genes involved in iron and lipid metabolisms are both affected in the mutant liver, suggesting novel roles of Abcb7 in the development of physiologically functional liver. The medaka abcb7 mutant thus could provide insights into the pathogenesis of XLSA/A as well as the normal function of the gene.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Ácidos Grasos/metabolismo , Hígado Graso/genética , Hierro de la Dieta/metabolismo , Oryzias/embriología , Oryzias/metabolismo , Animales , Hígado Graso/embriología , Hígado Graso/metabolismo , Hígado Graso/patología , Humanos , Hígado/embriología , Hígado/metabolismo , Mutación , Análisis de Secuencia por Matrices de Oligonucleótidos , Oryzias/genética
10.
Mech Dev ; 121(7-8): 739-46, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15210181

RESUMEN

In a genetic screen for mutations affecting organogenesis in the medaka, Oryzias latipes, we identified eight mutants with defects in embryonic hematopoiesis. These mutations were classified into seven complementation groups. In this paper, we characterize the five mutants that were confirmed in the next generation. The beni fuji mutant was defective in the generation of blood cells, exhibiting reduced blood cells at the initiation of circulation. Mutations in two genes, lady finger and ryogyoku, caused abnormal morphology of blood cells, i.e., deformation, along with a progressive decrease in the number of blood cells. The sekirei mutant exhibited photosensitivity with autofluorescent blood cells. Mutations in kyoho resulted in huge blood cells that were approximately three times longer than the wild-type blood cells. The spectrum of phenotypes identified in this study is similar to that of the zebrafish hematopoietic mutants except for the huge blood cells in kyoho. Our results demonstrate that medaka, as well as zebrafish, is a useful model to study hematopoiesis.


Asunto(s)
Hematopoyesis/genética , Mutación , Oryzias/embriología , Oryzias/genética , Animales , Células Sanguíneas/citología , Células Sanguíneas/fisiología , Diferenciación Celular/fisiología , Hematopoyesis/fisiología , Oryzias/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA